RhumbLine Advisers’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-28,709
| Closed | -$33.6K | – | 4412 |
|
|
2024
Q2 | $33.6K | Sell |
28,709
-48,389
| -63% | -$56.6K | ﹤0.01% | 3783 |
|
|
2024
Q1 | $697K | Buy |
77,098
+1,311
| +2% | +$11.9K | ﹤0.01% | 2455 |
|
|
2023
Q4 | $824K | Buy |
75,787
+5,082
| +7% | +$55.2K | ﹤0.01% | 2373 |
|
|
2023
Q3 | $569K | Buy |
70,705
+3,803
| +6% | +$30.6K | ﹤0.01% | 2543 |
|
|
2023
Q2 | $727K | Buy |
+66,902
| New | +$727K | ﹤0.01% | 2464 |
|
|
2022
Q2 | – | Sell |
-37,114
| Closed | -$347K | – | 3273 |
|
|
2022
Q1 | $347K | Buy |
37,114
+1,257
| +4% | +$11.8K | ﹤0.01% | 2591 |
|
|
2021
Q4 | $426K | Sell |
35,857
-925
| -3% | -$11K | ﹤0.01% | 2576 |
|
|
2021
Q3 | $419K | Buy |
36,782
+1,675
| +5% | +$19.1K | ﹤0.01% | 2623 |
|
|
2021
Q2 | $630K | Buy |
35,107
+9,131
| +35% | +$164K | ﹤0.01% | 2452 |
|
|
2021
Q1 | $402K | Sell |
25,976
-618
| -2% | -$9.56K | ﹤0.01% | 2587 |
|
|
2020
Q4 | $324K | Buy |
26,594
+3,797
| +17% | +$46.3K | ﹤0.01% | 2632 |
|
|
2020
Q3 | $293K | Sell |
22,797
-3,465
| -13% | -$44.5K | ﹤0.01% | 2528 |
|
|
2020
Q2 | $267K | Buy |
26,262
+7,831
| +42% | +$79.6K | ﹤0.01% | 2634 |
|
|
2020
Q1 | $150K | Buy |
18,431
+1,705
| +10% | +$13.9K | ﹤0.01% | 2678 |
|
|
2019
Q4 | $145K | Buy |
16,726
+626
| +4% | +$5.43K | ﹤0.01% | 2826 |
|
|
2019
Q3 | $99K | Sell |
16,100
-159
| -1% | -$978 | ﹤0.01% | 2887 |
|
|
2019
Q2 | $270K | Buy |
16,259
+2,320
| +17% | +$38.5K | ﹤0.01% | 2652 |
|
|
2019
Q1 | $233K | Buy |
13,939
+1,898
| +16% | +$31.7K | ﹤0.01% | 2679 |
|
|
2018
Q4 | $138K | Buy |
12,041
+3,954
| +49% | +$45.3K | ﹤0.01% | 2830 |
|
|
2018
Q3 | $323K | Sell |
8,087
-588
| -7% | -$23.5K | ﹤0.01% | 2478 |
|
|
2018
Q2 | $245K | Buy |
+8,675
| New | +$245K | ﹤0.01% | 2639 |
|